Skip to main content
News Tag: news
Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer (NRG-CC009)
Read More
Should SRS be Delivered Before or After Surgery for Patients with Brain Metastases? (NRG-BN012)
Read More
NRG Oncology Trial Does Not Improve Overall Survival, but Shows Improvements in Several Clinical Outcomes for Men with Intermediate-Risk Prostate Cancer
Read More
NRG Oncology Study Results Confirm Conventional External Beam Radiotherapy Should Remain Standard of Care in Treating Localized Vertebral Metastases of the Spine
Read More
Webinar: NRG-GI004 / SWOG S1610 COMMIT Study Amendment 9 Overview
Read More
Show Me the Money
Read More
FORTE at #NRG2023!
Read More
Comparing Selumetinib and Olaparib to Selumetinib Alone for Ovarian and Endometrial Cancers with RAS Pathway Mutations (EAY191-N4, A ComboMATCH Treatment Trial)
Read More
Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone-Receptor Positive Metastatic Breast Cancer (EAY191-N2, A ComboMATCH Treatment Trial)
Read More
WVOCA Donates Additional Funds to the NRG Oncology Health Equity Fellowship Program
Read More